STAA•businesswire•
STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process
Summary
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued the following statement to correct misinformation regarding its robust go-shop process to evaluate available alternatives to the pending merger with Alcon (SIX/NYSE: ALC). Broadwood Partners, L.P. (“Broadwood”) falsely alleges there was a credible buyer who had a strong interest in acquiri
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 11, 2025 by businesswire